1HP for LTBI Treatment: Key Considerations & Controversies

DESCRIPTION & OVERALL GOAL
This webinar will address the nuances and controversies surrounding the 1HP regimen as a short-course option for treatment for LTBI. The session will explore how the clinical trial data translates into complex clinical decisions and the practicalities in public health settings. Panelists will discuss the latest clinical data, efficacy vs. real-world effectiveness, implementation barriers, and ongoing debates in specific patient populations.  

WHO SHOULD ATTEND
This webinar is open to clinicians, nurses, TB program staff, and other healthcare professionals involved in the diagnosis, treatment, and management of persons with TB infection in various settings. Providers and healthcare teams working in the primary care settings may find this webinar useful for keeping up to date on short course options for treatment of LTBI.

OBJECTIVES
Upon completion of this webinar, participants should be better able:

• Describe evidence and guideline gaps for the 1HP regimen.
• Discuss the efficacy, tolerability, and safety of the 1HP regimen for LTBI treatment, including for specific populations and circumstances.
• Understand key clinical, programmatic, and patient concerns regarding practical operational strategies, feasibility, and acceptability.

DISCLOSURE POLICY
The relevant financial relationships of all individuals who affect the content of continuing education activities and any discussion of off-label/investigational uses will be disclosed to the audience at the time of the activity.

REGISTRATION
Registration is available at: Webinar Registration

After submitting your registration, we recommend that you add the webinar to your calendar for easy access to the connection details on the day of the webinar.

Continuing education credits will NOT be provided for this webinar.

FUNDING DISCLOSURE
Funding for this webinar was made possible by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government. 

For additional course information, questions, or concerns, please contact Denise Dean at 973-972-1261 or by email denise.dean@rutgers.edu.